共 50 条
- [36] FDA approves first EGFR exon 20 targeted kinase inhibitor Nature Reviews Drug Discovery, 2021, 20 : 806 - 806
- [39] Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (06):